The American Journal of Managed Care

In Study Across 15 Centers, 35% of Patients With MCL See Progression After CAR T-Cell Therapy

Approximately one-third of patients with relapsed or refractory mantle cell lymphoma (MCL) in this study treated with CAR T-cell therapy experienced disease progression, with a median progression time ...
Medicine Buffalo

Two UB Studies on MS Patients Reveal How Paramagnetic Rim Lesions Evolve and What They Mean for Disease Progression

BUFFALO, N.Y. – In recent years, researchers studying multiple sclerosis have concluded that white matter lesion volume in the brain, long considered the best way to monitor MS disease progression, ...
The American Journal of Managed Care

Study Identifies Risk Factors for Progression From Low-Risk MDS

The findings show most patients with low-risk myelodysplastic syndrome (MDS) will die before progression. A new analysis of nearly 2000 patients with low-risk myelodysplastic syndrome (MDS) has ...
UPI

Fish-rich diet can slow progression of multiple sclerosis, study suggests

Feb. 25 (UPI) --A diet rich in fish may help slow down the progression of the incurable, often disabling autoimmune disease of multiple sclerosis, according to new, long-term Swedish study published ...